Not cancer · Austria
Alzheimer disease
How is it diagnosed today? There is no simple, reliable test. The doctor checks your general health, may order blood tests and ask about your medicines to rule out other causes, and asks you to do some memory and thinking tasks. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.5 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Symptom medicines (e.g. donepezil) plus support. NHS
5 medicines are approved for this disease in Austria:
- Donanemab (Kisunla) – approved in 2025
- Lecanemab (Leqembi) – approved in 2025
- Memantine (Memantine Mylan, Memantine ratiopharm, memantine hydrochloride) – approved in 2013
- Memantine hydrochloride (Memantine Merz) – approved in 2012
- Rivastigmine (Rivastigmine, Exelon, Exelon Patch) – approved in 2009
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (7)
- Benzgalantamine (Zunveyl) – approved for it in the US
- Brexpiprazole (Rexulti) – approved for it in the US
- Dextromethorphan and bupropion (Auvelity) – approved for it in the US
- Donepezil (Aricept, Donepezil Sandoz) – approved for it in the US, Switzerland, and France
- Galantamine (Galantamine, Reminyl PR, Galantamine Biogaran Lp) – approved for it in the US, Switzerland, and France
- Memantine and donepezil (Namzaric) – approved for it in the US
- Risperidone (Risperdal, Risperidone Eg) – approved for it in France
Being tested in people
5 open trials in Austria, 618 worldwide. See the trials
- ACP-204 (Phase 3)
- AR1001 (Phase 3)
- Atomoxetine (Phase 3)
- buntanetap/posiphen (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 4 were in animals and 1 in the lab. See them
No proof it works
We checked 13 things people say help with this disease against the research. See how far each has been tested
No trial in people on record yet:
- Mistletoe extract (only single reports in people)
- Hyperthermia (animal studies only)
- Ivermectin (animal studies only)
- Dichloroacetate (DCA) (lab studies only)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
5 open trials in Austria, and 1 opening soon or by invitation
Long-Term Registry Following People With Alzheimer's and Related Dementias
NCT07213700 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Schwarzach – Kardinal Schwarzenberg Klinikum
Age 18 and over
Contact the trial teamSinging lessons to test memory in people with Alzheimer's disease
NCT06611878 · ClinicalTrials.gov
- Vienna – University of Vienna
Age 65 and over
Contact the trial teamTests NSC001 for safety in mild to moderate Alzheimer's disease
NCT06995573 · ClinicalTrials.gov
- Graz – University Hospital Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Salzburg – Gemeinnuetzige Salzburger Landeskliniken Betriebsgesellschaft mbH
Ages 50 to 85
Contact the trial teamTests a personalized lifestyle program for older adults at risk of memory decline
NCT07376135 · ClinicalTrials.gov
- Graz – Medical University of Innsbruck
- Innsbruck – Medical University of Innsbruck
- Vienna – Medical University of Vienna
Ages 55 to 75
Contact the trial teamScanning a Transport Protein in Healthy Adults and Alzheimer's Patients
2024-517851-11-00 · EU Clinical Trials Register
- Vienna – Medical University of Vienna
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudying how a brain scan tracer moves in healthy adults and people with Alzheimer's
2024-517875-19-00 · EU Clinical Trials Register
- Vienna – Medical University of Vienna
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
Available abroad (811 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Brain Immuno-PET
2026-525254-10-00 · EU Clinical Trials Register
Countries: Netherlands
- Amsterdam, Netherlands – Amsterdam UMC Stichting
Age 18 and over
Contact the trial teamTests a plant-based supplement's effect on memory and thinking in older adults
NCT07226674 · ClinicalTrials.gov
Countries: United Kingdom
- Coleraine, United Kingdom – Ulster University, Human Intervention Studies Unit
Age 50 and over
Contact the trial teamTests ALN-APP, an injected drug, in early-onset Alzheimer's disease
NCT05231785 · ClinicalTrials.gov
Countries: United Kingdom, Netherlands, Canada and 1 more
- Sheffield, United Kingdom – hospital not given
- Amsterdam, Netherlands – Brain Research Center Amsterdam B.V.
- Montreal, Canada – hospital not given
Age 18 and over
Contact the trial teamLong-Term Safety Study of KarXT for Psychosis in Alzheimer's Disease
NCT05980949 · ClinicalTrials.gov
Countries: Belgium, Bulgaria, Czechia and 27 more
- Alken, Belgium – Anima
- Jette, Belgium – UZ Brussel
- Kortrijk, Belgium – Algemeen Ziekenhuis Groeninge
Ages 55 to 90
Contact the trial teamTests ML-007C-MA for hallucinations and delusions in Alzheimer's disease psychosis
NCT06887192 · ClinicalTrials.gov
Countries: Czechia, France, Hungary and 11 more
- Choceň, Czechia – NEUROHK s r o
- Prague, Czechia – Praglandia s.r.o.
- Strasbourg, France – Les Hopitaux Universitaires de Strasbourg
Ages 55 to 90
Contact the trial teamLong-term study of KarXT and KarX-EC for agitation in Alzheimer's disease
NCT06937229 · ClinicalTrials.gov
Countries: Bulgaria, Czechia, Germany and 23 more
- Pleven, Bulgaria – Medical Center Medconsult Pleven OOD
- Sofia, Bulgaria – Mental Health Center Sofia EOOD
- Brno-Líšeň, Czechia – Neuro Health Centrum s.r.o.
Ages 55 to 90
Contact the trial teamLong-term safety of ML-007C-MA for hallucinations and delusions in Alzheimer's disease
NCT07459660 · ClinicalTrials.gov
Countries: Czechia, France, Hungary and 6 more
- Choceň, Czechia – NEUROHK s r o
- Prague, Czechia – Praglandia s.r.o.
- Strasbourg, France – Les Hopitaux Universitaires de Strasbourg
Ages 55 to 91
Contact the trial teamEye pupil measurements in virtual reality for memory problems and depression
NCT07402356 · ClinicalTrials.gov
Countries: Germany
- München, Germany – Max Planck Institute of Psychiatry
Ages 18 to 80
Contact the trial teamAI to spot early Alzheimer's disease in people with memory concerns
NCT07652931 · ClinicalTrials.gov
Countries: Italy
- Milan, Italy – San Raffaele Neurology Unit
Age 40 and over
Contact the trial teamTesting Treatments to Slow Early Alzheimer's in People with Inherited Gene Changes
2024-517187-36-01 · EU Clinical Trials Register
Countries: Spain, France, Italy
- Barcelona, Spain – Hospital Clinic de Barcelona
- Bron, France – Hospices Civils de Lyon
- Toulouse, France – Centre Hospitalier Universitaire de Toulouse
Age 18 and over
Contact the trial teamObserves safety of Leqembi in UK people with Alzheimer's disease
NCT07781345 · ClinicalTrials.gov
Countries: United Kingdom
- Edinburgh, United Kingdom – Scottish Brain Sciences
- London, United Kingdom – Recognition Health Limited
- Motherwell, United Kingdom – Neuroclnx
No age limit given in the registry
Contact the trial teamTests KarXT for agitation in people with Alzheimer's disease
NCT07011732 · ClinicalTrials.gov
Countries: Bulgaria, Spain, Greece and 12 more
- Pleven, Bulgaria – Medical Center Medconsult Pleven OOD
- Sofia, Bulgaria – Mental Health Center Sofia EOOD
- Elche, Spain – Hospital General Universitario de Elche
Ages 55 to 90
Contact the trial teamEXV-802 and EXV-801 for agitation in people with Alzheimer's disease dementia
NCT07284472 · ClinicalTrials.gov
Countries: Czechia, Germany, Spain and 6 more
- Kladno, Czechia – Brain-Soultherapy s.r.o.
- Berlin, Germany – Praxis Dr. med. Kirsten Hahn
- Chemnitz, Germany – Pharmakologisches Studienzentrum Chemnitz GmbH
Ages 55 to 90
Contact the trial teamTesting SAR448851, a daily pill, in people with early Alzheimer's disease
NCT07688213 · ClinicalTrials.gov
Countries: Germany, Spain, United Kingdom and 4 more
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
- Bremen, Germany – Gesundheit Nord gGmbH Klinikverbund Bremen
- Cologne, Germany – Universitaetsklinikum Koeln AöR
Ages 55 to 85
Contact the trial teamTrontinemab for people at risk of developing Alzheimer's disease who have no memory problems
NCT07717411 · ClinicalTrials.gov
Countries: United Kingdom, Argentina, Australia and 7 more
- Aberdeen, United Kingdom – Scottish Brain Sciences
- Birmingham, United Kingdom – Re:Cognition Health - Birmingham
- Chertsey, United Kingdom – Surrey and Borders NHS Foundation Trust
Ages 55 to 80
Contact the trial teamTests RO7568282 against a placebo in early Alzheimer's disease
NCT07781657 · ClinicalTrials.gov
Countries: Belgium, Germany, Spain and 6 more
- Jette, Belgium – UZ Brussel
- Kortrijk, Belgium – Algemeen Ziekenhuis Groeninge
- Leuven, Belgium – UZ Leuven
Ages 50 to 90
Contact the trial teamTests ACP-204 for psychosis in people with Alzheimer's disease
NCT06159673 · ClinicalTrials.gov
Countries: Bulgaria, Czechia, Spain and 9 more
- Pleven, Bulgaria – Medical Center Medconsult Pleven OOD
- Plovdiv, Bulgaria – University Multiprofile Hospital For Active Treatment Saint Georgi EAD
- Plovdiv, Bulgaria – Medical Center Spectar Plovdiv EOOD
Ages 55 to 95
Contact the trial teamBrain Stimulation With Memory Training for Mild Alzheimer's Disease
NCT07839650 · ClinicalTrials.gov
Countries: Italy
- Brescia, Italy – IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli
- Milan, Italy – IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
Age 18 and over
Contact the trial teamTear tests to look for Alzheimer's disease markers
NCT06661564 · ClinicalTrials.gov
Countries: France
- Tours, France – CHRU de Tours
Age 18 and over
Contact the trial teamComparing Two Types of Strength Training in Older Adults With Alzheimer's Disease
NCT07918417 · ClinicalTrials.gov
Countries: Spain
- Valladolid, Spain – Miguel de Cervantes European University
Age 60 and over
Contact the trial teamLong-term study of ACP-204 for psychosis linked to Alzheimer's disease
NCT06194799 · ClinicalTrials.gov
Countries: Bulgaria, Czechia, Spain and 9 more
- Pleven, Bulgaria – Medical Center Medconsult Pleven OOD
- Plovdiv, Bulgaria – University Multiprofile Hospital For Active Treatment Saint Georgi EAD
- Plovdiv, Bulgaria – Medical Center Spectar Plovdiv EOOD
Ages 55 to 95
Contact the trial teamTests ITI-1284 for psychosis in people with Alzheimer's disease
NCT06540833 · ClinicalTrials.gov
Countries: Bulgaria, Czechia, Spain and 7 more
- Blagoevgrad, Bulgaria – Medical Center Sv Dimitar Blagoevgrad
- Cherven Bryag, Bulgaria – Ambulatory for Individual Practice for Specialized Medical Care in Psychiatry Dr. Ivo Natsov ET
- Sofia, Bulgaria – Mental Health Centre Prof. N Shipkovenski EOOD
Age 55 and over
Contact the trial teamTests ITI-1284 for agitation linked to Alzheimer's dementia
NCT06651567 · ClinicalTrials.gov
Countries: Bulgaria, Czechia, Spain and 5 more
- Lovech, Bulgaria – State Psychiatric Hospital - Lovech
- Pleven, Bulgaria – Medical Center Medconsult Pleven OOD
- Sofia, Bulgaria – Medical Center Intermedica Ltd.
Age 55 and over
Contact the trial teamTests KarXT with KarX-EC for agitation in Alzheimer's disease
NCT07011745 · ClinicalTrials.gov
Countries: Czechia, Germany, France and 11 more
- Brno-Líšeň, Czechia – Neuro Health Centrum s.r.o.
- Choceň, Czechia – NEUROHK s r o
- Olomouc, Czechia – AGE Centrum s.r.o.
Ages 55 to 90
Contact the trial teamTesting Movement Training and Devices in People With Movement Disorders and Healthy Adults
NCT07066137 · ClinicalTrials.gov
Countries: Italy
- Messina, Italy – IRCCS Centro Neurolesi Bonino Pulejo
Ages 18 to 70
Contact the trial teamUsing AI to analyze speech in Alzheimer's, Parkinson's and other dementias
NCT07906769 · ClinicalTrials.gov
Countries: Italy
- Bari, Italy – Istituti Clinici Scientifici Maugeri IRCCS Bari
Ages 40 to 90
Contact the trial teamBuilding an Italian test of famous-face recognition for people with stroke or dementia
NCT07911878 · ClinicalTrials.gov
Countries: Italy
- Bari, Italy – Istituti Clinici Scientifici Maugeri IRCCS Bari
- Castel Goffredo, Italy – IRCCS Maugeri Castel Goffredo
- Lumezzane, Italy – IRCCS Maugeri Lumezzane
Ages 40 to 85
Contact the trial teamBrain scans of synapses, tau and inflammation in Alzheimer's, healthy adults and centenarians
NCT07906054 · ClinicalTrials.gov
Countries: Belgium
- Leuven, Belgium – University Hospitals Leuven
Age 18 and over
Contact the trial teamEye Imaging to Study Retina Changes in People With Memory Impairment
NCT04389437 · ClinicalTrials.gov
Countries: France
- Paris, France – Hôpital Fondation A. de Rothschild
Age 18 and over
Contact the trial teamTests LY3954068 safety in people with early Alzheimer's disease
NCT06297590 · ClinicalTrials.gov
Countries: United Kingdom, Japan, United States
- London, United Kingdom – National Hospital for Neurology and Neurosurgery (UCLH)
- Sheffield, United Kingdom – Royal Hallamshire Hospital
- Southampton, United Kingdom – University Hospital Southampton
Ages 50 to 85
Contact the trial teamKarXT Tested for Psychosis in People With Alzheimer's Disease
NCT06585787 · ClinicalTrials.gov
Countries: Belgium, Bulgaria, Germany and 22 more
- Alken, Belgium – Anima
- Jette, Belgium – UZ Brussel
- Kortrijk, Belgium – Algemeen Ziekenhuis Groeninge
Ages 55 to 90
Contact the trial teamTesting KarXT with KarX-EC for memory problems in Alzheimer's disease
NCT06976216 · ClinicalTrials.gov
Countries: Czechia, Germany, Spain and 16 more
- Brno-Líšeň, Czechia – Neuro Health Centrum s.r.o.
- Olomouc, Czechia – AGE Centrum s.r.o.
- Prague, Czechia – FORBELI s.r.o.
Ages 60 to 85
Contact the trial teamSpeech and language therapy study for people with primary progressive aphasia
NCT06739967 · ClinicalTrials.gov
Countries: Italy
- Bari, Italy – Istituti Clinici Scientifici Maugeri IRCCS
- Milan, Italy – IRCCS Ospedale San Raffaele
Ages 40 to 85
Contact the trial teamTesting MK-2214 in people with early Alzheimer's disease
NCT07033494 · ClinicalTrials.gov
Countries: Belgium, Spain, United Kingdom and 7 more
- Kortrijk, Belgium – Algemeen Ziekenhuis Groeninge
- Leuven, Belgium – UZ Leuven
- Barcelona, Spain – Hospital Clinic de Barcelona
Ages 50 to 85
Contact the trial teamStudies sleep and body temperature changes as signs of Alzheimer's in Down syndrome
2023-506609-21-00 · EU Clinical Trials Register
Countries: Spain
- Barcelona, Spain – Hospital de la Santa Creu i Sant Pau
Ages 18 to 64
Contact the trial teamScreening people with Alzheimer's disease for possible future studies
NCT07177352 · ClinicalTrials.gov
Countries: Denmark, Spain, Italy and 12 more
- Aalborg, Denmark – Aalborg Universitetshospital
- Aarhus N, Denmark – Aarhus Universitetshospital Skejby
- København Ø, Denmark – Rigshospitalet, Hukommelsesklinikken
Ages 50 to 90
Contact the trial teamTests KarXT for psychosis in people with Alzheimer's disease
NCT06126224 · ClinicalTrials.gov
Countries: Belgium, Switzerland, United Kingdom and 10 more
- Hasselt, Belgium – JESSA Ziekenhuis
- Leuven, Belgium – UZ Leuven
- Roeselare, Belgium – Algemeen Ziekenhuis Delta
Ages 55 to 90
Contact the trial teamBrain Tau Changes After Hip or Knee Replacement Surgery
NCT07871487 · ClinicalTrials.gov
Countries: Sweden
- Uppsala, Sweden – Uppsala University Hospital
Ages 55 to 75
Contact the trial teamMivelsiran Tested in Early Down Syndrome-Associated Alzheimer's Disease
NCT07636811 · ClinicalTrials.gov
Countries: Germany, Spain, Italy and 2 more
- Bremen, Germany – Gesundheit Nord gGmbH Klinikverbund Bremen
- Munich, Germany – LMU Klinikum Muenchen AöR
- Barcelona, Spain – Hospital de la Santa Creu i Sant Pau
Ages 40 to 55
Contact the trial teamRegistry following transcranial pulse stimulation treatment for Alzheimer's disease in Germany
NCT06313944 · ClinicalTrials.gov
Countries: Germany
- Bonn, Germany – Universitätsklinikum Bonn - Klinik für Parkinson, Schlaf- und Bewegungsstörungen
- Kempen, Germany – Hospital zum Heiligen Geist GmbH & Co KG Klinik für Neurologie und Neurorehabilitation
- Neuss, Germany – Neurologische Praxis Prof. Wojtecki
Ages 18 to 85
Contact the trial team
Showing 40 of 811. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- End-to-end deep learning for identifying Alzheimer's disease signatures in spectral fluorescence imaging of normal-appearing brain regions in 5xFAD mice.J Med Imaging (Bellingham) · 2026-11-06
- Neurotherapeutic potential of photobiomodulation in a 3D Model of Alzheimer's disease induced by oxidative stress.In Vitro Model · 2026-05-04
- Smoking and dementia risk: an updated systematic review and meta-analysis of 61 prospective cohort studies and implications for tobacco control.EClinicalMedicine · 2026-11-07
- Plasma biomarker signatures in patients with rapidly progressive dementia.Alzheimers Dement (Amst) · 2026-11-13
- ReviewElevated Phosphorylated Tau and Amyloid-Beta 42 in Sleep Apnoea: Evidence From a Systematic Review and Meta-Analysis.Biomed Res Int · 2026-01-01
Is it true?
Saw something on social media? Fact-check it now.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Alzheimer Austria
Self-help organisation for 35+ years: free confidential counselling by appointment (alzheimeraustria@aon.at), young-onset group, peer counselling, partner and adult-children groups, Alzheimer Cafe, carer course.
- Demenz Selbsthilfe Austria
Federation and umbrella organisation of dementia self-help groups in Austria (founded 2021); Alzheimer Europe full member.
- Demenzstrategie „Gut leben mit Demenz“
Public portal of Austria's national dementia strategy with material for people with dementia and relatives and links to regional services.
- Fonds Demenzhilfe Österreich (Volkshilfe Demenzhilfe)
Volkshilfe initiative giving financial aid to people with dementia at risk of poverty; information on counselling, self-help groups and care services.
- MAS Alzheimerhilfe
Dementia service points (information and practical help for people with dementia and relatives), guided self-help groups, Alzheimer holiday for couples, carer tips.
Phone: +43 6132 214 10
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (9)
- Alzheimer's Association
Free 24/7 Helpline (interpreters for 200+ languages), care consultations with dementia experts, local chapters, Community Resource Finder, ALZConnected online community.
- Alzheimer's Drug Discovery Foundation
Funds the early work on new Alzheimer's medicines, in universities and companies.
Phone: 212.901.8000
- BrightFocus Foundation
US nonprofit that funds research and provides public information on Alzheimer's disease, macular degeneration and glaucoma.
- Dementia Alliance International (DAI)
Organisation for people with a dementia diagnosis: free online peer support groups, webinars, Brain Health Hub, resources for care partners.
- Alzheimer Europe
Umbrella of national Alzheimer associations in 39 countries, with a member directory.
- Alzheimer's Disease International (ADI)
Global federation of dementia associations in 100+ countries: member associations list, find local support, dementia information, World Alzheimer Report.
- European Federation of Neurological Associations (EFNA)
Umbrella of 21 pan-European neurology patient groups; map of European neurology patient organisations.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.